Thanks for providing that again.
Is it safe to say that UBS are trying to keep the price down for now? Can someone confirm where they sit in our top20
- Forums
- ASX - By Stock
- GLN
- Canaccord research report target $2.60/share
Canaccord research report target $2.60/share, page-119
-
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GLN (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.3¢ |
Change
0.018(12.1%) |
Mkt cap ! $118.4M |
Open | High | Low | Value | Volume |
15.0¢ | 16.5¢ | 15.0¢ | $652.3K | 4.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 64823 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 875258 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 64823 | 0.160 |
18 | 921533 | 0.155 |
18 | 783771 | 0.150 |
19 | 2303367 | 0.145 |
17 | 1528707 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 875258 | 15 |
0.170 | 529079 | 14 |
0.175 | 303107 | 8 |
0.180 | 390581 | 13 |
0.185 | 210358 | 6 |
Last trade - 13.22pm 12/11/2024 (20 minute delay) ? |
Featured News
GLN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online